6:12 PM
 | 
Feb 13, 2013
 |  BC Extra  |  Company News

GSK, Vanderbilt in obesity deal

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) partnered with Vanderbilt University (Nashville, Tenn.) to discover, develop and commercialize positive allosteric modulators (PAMs) of melanocortin 4...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >